State-of-the-Art: Inflammatory and Metabolic Markers in Mood Disorders
- PMID: 32517269
- PMCID: PMC7345093
- DOI: 10.3390/life10060082
State-of-the-Art: Inflammatory and Metabolic Markers in Mood Disorders
Abstract
Mounting evidence highlights the involvement of inflammatory/immune systems and their relationships with neurotransmitters and different metabolic processes in mood disorders. Nevertheless, there is a general agreement that available findings are still inconclusive. Therefore, further investigations are required, aimed at deepening the role of possible alterations of biomarkers in the pathophysiology of mood disorders that might lead to more focused and tailored treatments. The present study is a comprehensive review on these topics that seem to represent intriguing avenues for the development of real innovative therapeutic strategies of mood disorders.
Keywords: hypothalamus-pituitary-adrenal axis; immune system; mood disorders; neuro-inflammation; neurotransmitters/neuroreceptors; neurotrophins; oxidative stress; serotonin; uric acid.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




References
-
- Price A.L., Marzani-Nissen G.R. Bipolar disorders: A review. Am. Fam. Physician. 2012;85:483–493. - PubMed
-
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association Press; Washington, DC, USA: 2013.